MLchartDataset catalogue

ABI-007

Term · Oncology and biomedicine · MLC-T-ONC-000104

A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. ABI-007 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called Abraxane, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.

Table 1. Record
IdentifierMLC-T-ONC-000104
FieldOncology and biomedicine
ExpansionsAbraxane; nanoparticle paclitaxel; paclitaxel albumin-stabilized nanoparticle formulation; protein-bound paclitaxel
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000104",
  "term": "ABI-007",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. ABI-007 may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. ABI-007 stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called Abraxane, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.",
  "expansions": [
    "Abraxane",
    "nanoparticle paclitaxel",
    "paclitaxel albumin-stabilized nanoparticle formulation",
    "protein-bound paclitaxel"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/abi-007/"
}

Record 172 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.